Corvus Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
12,517.00
94,386.00
134,896.00
90,055.00
114,597
Total Accounts Receivable
-
-
365.00
132.00
337
Other Current Assets
12.00
1,277.00
772.00
1,047.00
655
Total Current Assets
12,529.00
95,663.00
136,033.00
91,234.00
115,589
Net Property, Plant & Equipment
-
1,845.00
3,248.00
2,672.00
2,180
Other Assets
-
951.00
869.00
869.00
463
Total Assets
12,529.00
98,459.00
140,150.00
94,775.00
118,232
Accounts Payable
-
-
-
3,454.00
Other Current Liabilities
2,674.00
3,070.00
5,944.00
5,515.00
Total Current Liabilities
2,674.00
3,070.00
5,944.00
8,969.00
Other Liabilities
3.00
710.00
1,405.00
971.00
Total Liabilities
2,677.00
3,780.00
7,349.00
9,940.00
Common Equity (Total)
159.00
31,101.00
132,801.00
84,835.00
Total Shareholders' Equity
9,852.00
94,679.00
132,801.00
84,835.00
Total Equity
9,852.00
94,679.00
132,801.00
84,835.00
Liabilities & Shareholders' Equity
12,529.00
98,459.00
140,150.00
94,775.00
Preferred Stock (Carrying Value)
10,011.00
125,780.00
-
-
About Corvus Pharmaceuticals
View Profile
